Research progress of transcatheter aortic valve replacement related coronary obstruction_West China Medical Journal

Authors：

ZHU Lei , OU Yuanweixiang , LI Xi , LI Yijian ,  FENG Yuan ,  CHEN Mao

Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding?author：

FENG Yuan, Email: fynotebook@hotmail.com; CHEN Mao, Email: hmaochen@vip.sina.com

Keywords：

Transcatheter aortic valve replacement; Coronary obstruction; Complication

DOI：

10.7507/1002-0179.202008155

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Coronary artery obstruction is a rare but fatal complication of transcatheter aortic valve replacement. Although there is no accepted criteria to fully evaluate the occurrence of coronary artery obstruction, studies have revealed many important risk factors, and some preventive measures have also been found to reduce their occurrence. At present, transcatheter aortic valve replacement is in a stage of rapid development in China, but clinical medical workers’ knowledge of coronary artery obstruction as a complication still needs to be improved. This article discusses the incidence, risk factors, predictive assessment, prevention, treatment and prognosis of coronary artery obstruction complicated by transcatheter aortic valve replacement, so as to increase clinical medical workers’ understanding of this complication.

Citation： ZHU Lei, OU Yuanweixiang, LI Xi, LI Yijian, FENG Yuan, CHEN Mao. Research progress of transcatheter aortic valve replacement related coronary obstruction. West China Medical Journal, 2020, 35(9): 1039-1043. doi: 10.7507/1002-0179.202008155 Copy

1.	Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation, 2002, 106(24): 3006-3008.
2.	中國醫師協會心血管內科醫師分會結構性心臟病專業委員會. 經導管主動脈瓣置換術中國專家共識(2020 更新版). 中國介入心臟病學雜志, 2020, 28(6): 301-309.
3.	Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet, 2015, 385(9986): 2477-2484.
4.	Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med, 2010, 363(17): 1597-1607.
5.	Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med, 2019, 380(18): 1706-1715.
6.	Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation, 2017, 135(25): e1159-e1195.
7.	Rodés-Cabau J. Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol, 2011, 9(1): 15-29.
8.	Khatri PJ, Webb JG, Rodés-Cabau J, et al. Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med, 2013, 158(1): 35-46.
9.	Kodali S, Pibarot P, Douglas PS, et al. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J, 2015, 36(7): 449-456.
10.	Hansson NC, Grove EL, Andersen HR, et al. Transcatheter aortic valve thrombosis: incidence, predisposing factors, and clinical implications. J Am Coll Cardiol, 2016, 68(19): 2059-2069.
11.	Ribeiro HB, Nombela-Franco L, Urena M, et al. Coronary obstruction following transcatheter aortic valve implantation:a systematic review. JACC Cardiovasc Interv, 2013, 6(5): 452-461.
12.	Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights froma large multicenter registry. J Am Coll Cardiol, 2013, 62(17): 1552-1562.
13.	Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg, 2012, 42(5): S45-S60.
14.	Fetahovic T, Hayman S, Cox S, et al. The prophylactic chimney snorkel technique for the prevention of acute coronary occlusion in high risk for coronary obstruction transcatheter aortic valve replacement/implantation cases. Heart Lung Circ, 2019, 28(10): e126-e130.
15.	Buellesfeld L, Stortecky S, Kalesan B, et al. Aortic root dimensions among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv, 2013, 6(1): 72-83.
16.	Jabbour RJ, Tanaka A, Finkelstein A, et al. Delayed coronary obstruction after transcatheter aortic valve replacement. J Am Coll Cardiol, 2018, 71(14): 1513-1524.
17.	Ribeiro HB, Rodés-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart J, 2018, 39(8): 687-695.
18.	Akinseye OA, Jha SK, Ibebuogu UN. Clinical outcomes of coronary occlusion following transcatheter aortic valve replacement:a systematic review. Cardiovasc Revasc Med, 2018, 19(2): 229-236.
19.	Jilaihawi H, Kashif M, Fontana G, et al. Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol, 2012, 59(14): 1275-1286.
20.	Blanke P, Soon J, Dvir D, et al. Computed tomography assessment for transcatheter aortic valve in valve implantation: the vancouver approach to predict anatomical risk for coronary obstruction and other considerations. J Cardiovasc Comput Tomogr, 2016, 10(6): 491-499.
21.	Rambod M, Terrien EF, Dauerman HL. White line sign of impending coronary occlusion in transcatheter aortic valve replacement. Circ Cardiovasc Interv, 2017, 10(3): e005011.
22.	Valvo R, Costa G, Barbanti M. How to avoid coronary occlusion during TAVR valve-in-valve procedures. Front Cardiovasc Med, 2019, 6: 168.
23.	Palmerini T, Chakravarty T, Saia F, et al. Coronary protection to prevent coronary obstruction during TAVR: a multicenter international registry. JACC Cardiovasc Interv, 2020, 13(6): 739-747.
24.	Garot P. TAVR-related coronary obstruction: preventive wires or stenting?. JACC Cardiovasc Interv, 2020, 13(6): 748-750.
25.	Khan JM, Greenbaum AB, Babaliaros VC, et al. The BASILICA trial: prospective multicenter investigation of intentional leaflet laceration to prevent TAVR coronary obstruction. JACC Cardiovasc Interv, 2019, 12(13): 1240-1252.
26.	Lederman RJ, Babaliaros VC, Rogers T, et al. Preventing coronary obstruction during transcatheter aortic valve replacement: from computed tomography to BASILICA. JACC Cardiovasc Interv, 2019, 12(13): 1197-1216.
27.	Ye J, Lee AJ, Blanke P, et al. The first transapical transcatheter aortic valve-in-valve implantation using the J-valve system intoa failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction. Catheter Cardiovasc Interv, 2018, 92(6): 1209-1214.

1. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation, 2002, 106(24): 3006-3008.
2. 中國醫師協會心血管內科醫師分會結構性心臟病專業委員會. 經導管主動脈瓣置換術中國專家共識(2020 更新版). 中國介入心臟病學雜志, 2020, 28(6): 301-309.
3. Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet, 2015, 385(9986): 2477-2484.
4. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med, 2010, 363(17): 1597-1607.
5. Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med, 2019, 380(18): 1706-1715.
6. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation, 2017, 135(25): e1159-e1195.
7. Rodés-Cabau J. Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol, 2011, 9(1): 15-29.
8. Khatri PJ, Webb JG, Rodés-Cabau J, et al. Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann Intern Med, 2013, 158(1): 35-46.
9. Kodali S, Pibarot P, Douglas PS, et al. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J, 2015, 36(7): 449-456.
10. Hansson NC, Grove EL, Andersen HR, et al. Transcatheter aortic valve thrombosis: incidence, predisposing factors, and clinical implications. J Am Coll Cardiol, 2016, 68(19): 2059-2069.
11. Ribeiro HB, Nombela-Franco L, Urena M, et al. Coronary obstruction following transcatheter aortic valve implantation:a systematic review. JACC Cardiovasc Interv, 2013, 6(5): 452-461.
12. Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights froma large multicenter registry. J Am Coll Cardiol, 2013, 62(17): 1552-1562.
13. Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg, 2012, 42(5): S45-S60.
14. Fetahovic T, Hayman S, Cox S, et al. The prophylactic chimney snorkel technique for the prevention of acute coronary occlusion in high risk for coronary obstruction transcatheter aortic valve replacement/implantation cases. Heart Lung Circ, 2019, 28(10): e126-e130.
15. Buellesfeld L, Stortecky S, Kalesan B, et al. Aortic root dimensions among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv, 2013, 6(1): 72-83.
16. Jabbour RJ, Tanaka A, Finkelstein A, et al. Delayed coronary obstruction after transcatheter aortic valve replacement. J Am Coll Cardiol, 2018, 71(14): 1513-1524.
17. Ribeiro HB, Rodés-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart J, 2018, 39(8): 687-695.
18. Akinseye OA, Jha SK, Ibebuogu UN. Clinical outcomes of coronary occlusion following transcatheter aortic valve replacement:a systematic review. Cardiovasc Revasc Med, 2018, 19(2): 229-236.
19. Jilaihawi H, Kashif M, Fontana G, et al. Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. J Am Coll Cardiol, 2012, 59(14): 1275-1286.
20. Blanke P, Soon J, Dvir D, et al. Computed tomography assessment for transcatheter aortic valve in valve implantation: the vancouver approach to predict anatomical risk for coronary obstruction and other considerations. J Cardiovasc Comput Tomogr, 2016, 10(6): 491-499.
21. Rambod M, Terrien EF, Dauerman HL. White line sign of impending coronary occlusion in transcatheter aortic valve replacement. Circ Cardiovasc Interv, 2017, 10(3): e005011.
22. Valvo R, Costa G, Barbanti M. How to avoid coronary occlusion during TAVR valve-in-valve procedures. Front Cardiovasc Med, 2019, 6: 168.
23. Palmerini T, Chakravarty T, Saia F, et al. Coronary protection to prevent coronary obstruction during TAVR: a multicenter international registry. JACC Cardiovasc Interv, 2020, 13(6): 739-747.
24. Garot P. TAVR-related coronary obstruction: preventive wires or stenting?. JACC Cardiovasc Interv, 2020, 13(6): 748-750.
25. Khan JM, Greenbaum AB, Babaliaros VC, et al. The BASILICA trial: prospective multicenter investigation of intentional leaflet laceration to prevent TAVR coronary obstruction. JACC Cardiovasc Interv, 2019, 12(13): 1240-1252.
26. Lederman RJ, Babaliaros VC, Rogers T, et al. Preventing coronary obstruction during transcatheter aortic valve replacement: from computed tomography to BASILICA. JACC Cardiovasc Interv, 2019, 12(13): 1197-1216.
27. Ye J, Lee AJ, Blanke P, et al. The first transapical transcatheter aortic valve-in-valve implantation using the J-valve system intoa failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction. Catheter Cardiovasc Interv, 2018, 92(6): 1209-1214.

West China Medical Journal

Research progress of transcatheter aortic valve replacement related coronary obstruction

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content